Interest in BPC 157 comes from its potential role in soft-tissue repair, joint comfort, gastrointestinal support, and overall recovery
In 2023, during Bidens Presidency, the Food and Drug Administration placed nineteen peptides, including BPC-157, on a do not compound list, citing potential significant safety risks that included immune reactions, pancreatitis, and accelerated growth of cancerous cells
But today
Evidence limitations : Strong rodent data for tendon/muscle repair, but almost no high-quality human trials
Oral long-term use No long-term data exists for oral tirzepatide formulations
Researchers have hinted at a potential process where cardiac fibroblasts transition into cells resembling cardiomyocytes.(14)In the end, the scholars observed that TB-500, when combined with cardiac reprogramming techniques, might collaboratively reduce potential harm to cardiac cells and foster its regeneration by activating inherent cells within the cardiac region
